retatrutide clinical trial results weight loss 2024 2025 press release Early data for demonstrates exceptional results, reaching approximately 21% placebo-adjusted weight loss by week 48. This performance significantly exceeds all other leading obesity medications currently under Lilly's triple agonist, retatrutide, demonstrated
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27






















